Toxicity of sulphonamide-diaminopyrimidine combinations: implications for future use.
D000890:Anti-Infective Agents / Q000009:adverse effects*; D004338:Drug Combinations / Q000009:adverse effects; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D011743:Pyrimidines / Q000009:adverse effects*; D013420:Sulfamethoxazole / Q000009:adverse effects; D013449:Sulfonamides / Q000009:adverse effects*; D014295:Trimethoprim / Q000009:adverse effects; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
D000890:Anti-Infective Agents; D004338:Drug Combinations; D011743:Pyrimidines; D013449:Sulfonamides; C017205:2,4-diaminopyrimidine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013420:Sulfamethoxazole